S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

MRKR Marker Therapeutics Inc

1.51

0.00 (0.00%)

Pre Market

Last Updated: 06:13:44

Delayed by 15 minutes

Form EFFECT - Notice of Effectiveness

Marker Therapeutics (NASDAQ:MRKR)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more Marker Therapeutics Charts.

Marker Therapeutics (NASDAQ:MRKR)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more Marker Therapeutics Charts.

Marker Therapeutics Inc News

Marker Therapeutics to Present at the H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference
Tuesday 25 February 2025 (1 day ago) • GlobeNewswire Inc.

Form 8-K - Current report
Wednesday 19 February 2025 (7 days ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 14 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 14 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 14 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 14 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Friday 14 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Tuesday 4 February 2025 (3 weeks ago) • Edgar (US Regulatory)

Form DEF 14A - Other definitive proxy statements
Tuesday 4 February 2025 (3 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 30 January 2025 (4 weeks ago) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Friday 17 January 2025 (1 month ago) • Edgar (US Regulatory)

Form PRE 14A - Other preliminary proxy statements
Monday 13 January 2025 (1 month ago) • Edgar (US Regulatory)

More Marker Therapeutics Inc News Articles

Alimera Sciences

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions